A new study has devised a new type of chimeric antigen-receptor (CAR) T cell -- a family of promising immunotherapies for cancer -- that can be switched on and off on demand.
from Top Technology News -- ScienceDaily https://ift.tt/36TcT5v
from Top Technology News -- ScienceDaily https://ift.tt/36TcT5v
Comments
Post a Comment